1. Home
  2. JAGX vs UGRO Comparison

JAGX vs UGRO Comparison

Compare JAGX & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • UGRO
  • Stock Information
  • Founded
  • JAGX 2013
  • UGRO 2014
  • Country
  • JAGX United States
  • UGRO United States
  • Employees
  • JAGX N/A
  • UGRO N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • UGRO Industrial Specialties
  • Sector
  • JAGX Health Care
  • UGRO Consumer Discretionary
  • Exchange
  • JAGX Nasdaq
  • UGRO Nasdaq
  • Market Cap
  • JAGX 3.4M
  • UGRO 3.8M
  • IPO Year
  • JAGX N/A
  • UGRO N/A
  • Fundamental
  • Price
  • JAGX $2.30
  • UGRO $0.31
  • Analyst Decision
  • JAGX Strong Buy
  • UGRO Strong Buy
  • Analyst Count
  • JAGX 1
  • UGRO 1
  • Target Price
  • JAGX $60.00
  • UGRO $3.00
  • AVG Volume (30 Days)
  • JAGX 97.0K
  • UGRO 622.8K
  • Earning Date
  • JAGX 08-12-2025
  • UGRO 07-29-2025
  • Dividend Yield
  • JAGX N/A
  • UGRO N/A
  • EPS Growth
  • JAGX N/A
  • UGRO N/A
  • EPS
  • JAGX N/A
  • UGRO N/A
  • Revenue
  • JAGX $11,552,000.00
  • UGRO $59,985,138.00
  • Revenue This Year
  • JAGX $22.41
  • UGRO N/A
  • Revenue Next Year
  • JAGX $30.00
  • UGRO $31.25
  • P/E Ratio
  • JAGX N/A
  • UGRO N/A
  • Revenue Growth
  • JAGX 13.93
  • UGRO N/A
  • 52 Week Low
  • JAGX $2.27
  • UGRO $0.26
  • 52 Week High
  • JAGX $110.75
  • UGRO $1.92
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 28.65
  • UGRO 46.74
  • Support Level
  • JAGX $2.28
  • UGRO $0.29
  • Resistance Level
  • JAGX $2.79
  • UGRO $0.33
  • Average True Range (ATR)
  • JAGX 0.14
  • UGRO 0.03
  • MACD
  • JAGX 0.09
  • UGRO 0.00
  • Stochastic Oscillator
  • JAGX 3.92
  • UGRO 57.18

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

Share on Social Networks: